Quality of Life of Adult Vitiligo Patients Using Camouflage: A Survey in a Chinese Vitiligo Community

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2019 Jan 25

PMID 30677057

Citations 11

Authors

Dian Chen

Hsiaohan Tuan

Eray Yihui Zhou

Dehua Liu

Yi Zhao

Affiliations

Soon will be listed here.

Abstract

Background: Vitiligo is an acquired depigmented skin disease resulting in white macules, which may significantly impair the quality of life (QoL) of the patients.

Objective: To estimate the QoL in Chinese vitiligo patients using camouflage with a more detailed description, and to identify the possible risk factors related to poor QoL.

Methods: An online survey was conducted in vitiligo patients using camouflage from a vitiligo community. Survey questions included demographic, clinical information, dermatology- and vitiligo-specific QoL questionnaires. Multivariate logistic analysis was performed to identify risk factors that related to poor QoL.

Results: In total, 884 respondents were included in the analyses, of which 413 (46.7%) were male. The score of DLQI was 5.83±5.75 (mean± SD). Age, gender, marriage status, occupational status, anogenital involvement, patient-perceived severity (presented by VAS score), symptoms as itching, pain, sunburn and koebner phenomenon, total cost of treatment and degree of satisfaction in camouflage therapy were independently associated with DLQI score (p<0.05).

Conclusion: Vitiligo has considerable impact on QoL of affected patients in Chinese population even when they were using camouflage. Camouflage might be helpful to improve QoL of the patients.

Citing Articles

Determining the Mean Dermatology Life Quality Index of Skin of Color (SOC) Patients With Vitiligo: A South Asian Perspective.

Habib A, Aslam H, Muhammad A, Mahajan A, Muhammad S, Ghafar R Cureus. 2024; 16(10):e70709.

PMID: 39493193 PMC: 11530142. DOI: 10.7759/cureus.70709.

Rosmarin D, Soliman A, Piercy J, Marwaha S, Anderson P, Camp H Dermatol Ther (Heidelb). 2024; 14(6):1633-1647.

PMID: 38824482 PMC: 11169145. DOI: 10.1007/s13555-024-01187-z.

Unveiling the Unseen Struggles: A Comprehensive Review of Vitiligo's Psychological, Social, and Quality of Life Impacts.

Salama A, Alnemr L, Khan A, Alfakeer H, Aleem Z, Ali-Alkhateeb M Cureus. 2023; 15(9):e45030.

PMID: 37829995 PMC: 10566310. DOI: 10.7759/cureus.45030.

Impact of Vitiligo on Life Quality of Patients: Assessment of Currently Available Tools.

Yang T, Lee C, Lan C Int J Environ Res Public Health. 2022; 19(22).

PMID: 36429664 PMC: 9690871. DOI: 10.3390/ijerph192214943.

The mental health associations of vitiligo: UK population-based cohort study.

Thompson A, Eleftheriadou V, Nesnas J BJPsych Open. 2022; 8(6):e190.

PMID: 36268886 PMC: 9634603. DOI: 10.1192/bjo.2022.591.

References

Salzes C, Abadie S, Seneschal J, Whitton M, Meurant J, Jouary T . The Vitiligo Impact Patient Scale (VIPs): Development and Validation of a Vitiligo Burden Assessment Tool. J Invest Dermatol. 2016; 136(1):52-8. DOI: 10.1038/JID.2015.398. View

Ongenae K, Dierckxsens L, Brochez L, van Geel N, Naeyaert J . Quality of life and stigmatization profile in a cohort of vitiligo patients and effect of the use of camouflage. Dermatology. 2005; 210(4):279-85. DOI: 10.1159/000084751. View

Dolatshahi M, Ghazi P, Feizy V, Hemami M . Life quality assessment among patients with vitiligo: comparison of married and single patients in Iran. Indian J Dermatol Venereol Leprol. 2009; 74(6):700. DOI: 10.4103/0378-6323.45141. View

Tanioka M, Yamamoto Y, Kato M, Miyachi Y . Camouflage for patients with vitiligo vulgaris improved their quality of life. J Cosmet Dermatol. 2010; 9(1):72-5. DOI: 10.1111/j.1473-2165.2010.00479.x. View

Ongenae K, van Geel N, de Schepper S, Naeyaert J . Effect of vitiligo on self-reported health-related quality of life. Br J Dermatol. 2005; 152(6):1165-72. DOI: 10.1111/j.1365-2133.2005.06456.x. View

Parsad D, Pandhi R, Dogra S, Kanwar A, Kumar B . Dermatology Life Quality Index score in vitiligo and its impact on the treatment outcome. Br J Dermatol. 2003; 148(2):373-4. DOI: 10.1046/j.1365-2133.2003.05097_9.x. View

Esmat S, El-Tawdy A, Hafez G, Zeid O, Abdel Halim D, Saleh M . Acral lesions of vitiligo: why are they resistant to photochemotherapy?. J Eur Acad Dermatol Venereol. 2011; 26(9):1097-104. DOI: 10.1111/j.1468-3083.2011.04215.x. View

Gupta V, Sreenivas V, Mehta M, Khaitan B, Ramam M . Measurement properties of the Vitiligo Impact Scale-22 (VIS-22), a vitiligo-specific quality-of-life instrument. Br J Dermatol. 2014; 171(5):1084-90. DOI: 10.1111/bjd.13093. View

Senol A, Yucelten A, Ay P . Development of a quality of life scale for vitiligo. Dermatology. 2013; 226(2):185-90. DOI: 10.1159/000348466. View

10.

Aust F, Diedenhofen B, Ullrich S, Musch J . Seriousness checks are useful to improve data validity in online research. Behav Res Methods. 2012; 45(2):527-35. DOI: 10.3758/s13428-012-0265-2. View

11.

Sampogna F, Raskovic D, Guerra L, Pedicelli C, Tabolli S, Leoni L . Identification of categories at risk for high quality of life impairment in patients with vitiligo. Br J Dermatol. 2008; 159(2):351-9. DOI: 10.1111/j.1365-2133.2008.08678.x. View

12.

Mishra N, Rastogi M, Gahalaut P, Agrawal S . Dermatology Specific Quality of Life in Vitiligo Patients and Its Relation with Various Variables: A Hospital Based Cross-sectional Study. J Clin Diagn Res. 2014; 8(6):YC01-3. PMC: 4129253. DOI: 10.7860/JCDR/2014/8248.4508. View

13.

Krishna G, Ramam M, Mehta M, Sreenivas V, Sharma V, Khandpur S . Vitiligo impact scale: an instrument to assess the psychosocial burden of vitiligo. Indian J Dermatol Venereol Leprol. 2013; 79(2):205-10. DOI: 10.4103/0378-6323.107637. View

14.

Budania A, Parsad D, Kanwar A, Dogra S . Comparison between autologous noncultured epidermal cell suspension and suction blister epidermal grafting in stable vitiligo: a randomized study. Br J Dermatol. 2012; 167(6):1295-301. DOI: 10.1111/bjd.12007. View

15.

Wang K, Wang K, Zhang Z . Health-related quality of life and marital quality of vitiligo patients in China. J Eur Acad Dermatol Venereol. 2010; 25(4):429-35. DOI: 10.1111/j.1468-3083.2010.03808.x. View

16.

Bae J, Lee S, Kim T, Yeom S, Shin J, Lee W . Factors affecting quality of life in patients with vitiligo: a nationwide study. Br J Dermatol. 2017; 178(1):238-244. DOI: 10.1111/bjd.15560. View

17.

Silverberg J, Silverberg N . Association between vitiligo extent and distribution and quality-of-life impairment. JAMA Dermatol. 2013; 149(2):159-64. DOI: 10.1001/jamadermatol.2013.927. View

18.

Singh C, Parsad D, Kanwar A, Dogra S, Kumar R . Comparison between autologous noncultured extracted hair follicle outer root sheath cell suspension and autologous noncultured epidermal cell suspension in the treatment of stable vitiligo: a randomized study. Br J Dermatol. 2013; 169(2):287-93. DOI: 10.1111/bjd.12325. View

19.

Speeckaert R, van Geel N . Vitiligo: An Update on Pathophysiology and Treatment Options. Am J Clin Dermatol. 2017; 18(6):733-744. DOI: 10.1007/s40257-017-0298-5. View

20.

Lilly E, Lu P, Borovicka J, Victorson D, Kwasny M, West D . Development and validation of a vitiligo-specific quality-of-life instrument (VitiQoL). J Am Acad Dermatol. 2012; 69(1):e11-8. DOI: 10.1016/j.jaad.2012.01.038. View